Importantly, while direct trAb-mediated destruction of tumor cells was only moderately improved by combination with CTLA-4 inhibition, the immunologic memory elicited by the combination treatment was indeed considerably enhanced. The gene discussed is CTLA4; the disease is neoplasm.